AXIM Biotechnologies, Inc.
General ticker "AXIM" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.6M (TTM average)
AXIM Biotechnologies, Inc. follows the US Stock Market performance with the rate: 25.6%.
Estimated limits based on current volatility of 11.5%: low 0.02$, high 0.03$
Factors to consider:
- Total employees count: 7 (-22.2%) as of 2023
- Top business risk factors: Pandemic risks, Liquidity and credit risks, Inflationary pressures, Geopolitical risks, Market competition
- Current price 180.1% above estimated high
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.00$, 0.01$]
- 2025-12-31 to 2026-12-31 estimated range: [0.00$, 0.01$]
Financial Metrics affecting the AXIM estimates:
- Positive: with PPE of -0.2 at the end of fiscal year the price was very low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -147.23 <= 0.33
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Investing cash flow per share per price, % of -0.49 > -0.66
- Positive: Shareholder equity ratio, % of -302.25 <= 18.93
Short-term AXIM quotes
Long-term AXIM plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.01MM | $0.04MM | $0.07MM |
| Operating Expenses | $4.66MM | $2.79MM | $1.83MM |
| Operating Income | $-4.65MM | $-2.75MM | $-1.76MM |
| Non-Operating Income | $-1.59MM | $-5.31MM | $-1.75MM |
| Interest Expense | $1.88MM | $1.20MM | $0.64MM |
| R&D Expense | $0.15MM | $0.13MM | $0.04MM |
| Income(Loss) | $-6.24MM | $-8.06MM | $-3.51MM |
| Profit(Loss)* | $-5.96MM | $-8.06MM | $-3.51MM |
| Stockholders Equity | $-4.83MM | $-7.66MM | $-10.42MM |
| Assets | $4.21MM | $4.12MM | $3.45MM |
| Operating Cash Flow | $-2.04MM | $-1.03MM | $-0.86MM |
| Capital expenditure | $0.01MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.01MM | $0.00MM | $-0.00MM |
| Financing Cash Flow | $1.65MM | $1.14MM | $0.70MM |
| Earnings Per Share** | $-0.04 | $-0.04 | $-0.01 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.